CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
1.990
-0.380 (-16.03%)
At close: Oct 17, 2025, 4:00 PM EDT
2.070
+0.080 (4.02%)
Pre-market: Oct 20, 2025, 7:34 AM EDT

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
21269236223
Market Cap Growth
-81.52%-83.24%-70.89%6.05%-
Enterprise Value
01470236-
Last Close Price
1.99120.0022000.0020540.6019820.00
PB Ratio
--6.081574.06-21.45-29.01
Debt / Equity Ratio
-0.70-0.8367.45-0.06-
Quick Ratio
0.430.440.430.0211.20
Current Ratio
0.560.500.561.3813.88
Return on Assets (ROA)
-156.89%-178.66%-20.20%-1.63%-
Return on Capital (ROIC)
--758.66%---
Earnings Yield
-1747.28%-72.13%-10.61%-0.28%-0.24%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q